Advertisement

Pregnancy-associated desmoid fibromatosis: A Dutch multi-centre retrospective study

Published:November 10, 2022DOI:https://doi.org/10.1016/j.ejso.2022.11.009

      Abstract

      Introduction

      The development of desmoid fibromatosis (DF) is associated with pregnancy. The current treatment consensus recommends active surveillance (AS). However, data in pregnancy-associated DF is scarce and it is uncertain whether AS is the best management strategy for this DF-subgroup. The aim of this study was to describe demographic, tumor, obstetric, treatment characteristics and treatment outcome in pregnancy-associated DF.

      Methods

      Female DF patients who were 18–50 years old at time of diagnosis (2000–2020) and had a history (≤5 years) of pregnancy at time of diagnosis were included.

      Results

      Overall, 62 patients were included. The most common locations were abdominal wall (74%), pelvis (10%) and extremities (10%). Mutational analysis was conducted in 31 patients of which 94% had CTNNB1-mutations. Ten patients (16%) were diagnosed during pregnancy, while the remainder were diagnosed after pregnancy with a median time from delivery to diagnosis of 19 months (1–60). The frontline management was AS in 38 patients (61%) of whom 12 (33%) developed progressive disease and surgery in 23 patients (37%). In total, 30 patients underwent surgery and five had local recurrence (17%). Positive resection margins were no prognostic factor. Nine patients received systemic treatment in second- or third-line.

      Conclusions

      Pregnancy-associated DF generally has an indolent behavior, where our results underscore the difficulty of establishing a clear definition of this entity. This study shows that AS should be the frontline management strategy for pregnancy-associated DF. When active treatment is indicated, surgery is a good option with low recurrence rates, even with positive (R1) resection margins.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. WHO classification of tumours editorial board: soft tissue and bone tumours. fifth ed. IARC, Geneva, Switzerland2020
        • Otero S.
        • Moskovic E.C.
        • Strauss D.C.
        • Benson C.
        • Miah A.B.
        • Thway K.
        • et al.
        Desmoid-type fibromatosis.
        Clin Radiol. 2015; 70: 1038-1045
        • Crago A.M.
        • Chmielecki J.
        • Rosenberg M.
        • O'Connor R.
        • Byrne C.
        • Wilder F.G.
        • et al.
        Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
        Genes Chromosomes Cancer. 2015; 54: 606-615
        • Mullen J.T.
        • DeLaney T.F.
        • Rosenberg A.E.
        • Le L.
        • Iafrate A.J.
        • Kobayashi W.
        • et al.
        beta-Catenin mutation status and outcomes in sporadic desmoid tumors.
        Oncol. 2013; 18: 1043-1049
        • van Broekhoven D.L.
        • Verhoef C.
        • Grunhagen D.J.
        • van Gorp J.M.
        • den Bakker M.A.
        • Hinrichs J.W.
        • et al.
        Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis.
        Ann Surg Oncol. 2015; 22: 1464-1470
        • Le Guellec S.
        • Soubeyran I.
        • Rochaix P.
        • Filleron T.
        • Neuville A.
        • Hostein I.
        • et al.
        CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.
        Mod Pathol. 2012; 25: 1551-1558
        • Nieuwenhuis M.H.
        • Casparie M.
        • Mathus-Vliegen L.M.
        • Dekkers O.M.
        • Hogendoorn P.C.
        • Vasen H.F.
        A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses.
        Int J Cancer. 2011; 129: 256-261
        • Kasper B.
        • Strobel P.
        • Hohenberger P.
        Desmoid tumors: clinical features and treatment options for advanced disease.
        Oncol. 2011; 16: 682-693
        • van Broekhoven D.L.
        • Grunhagen D.J.
        • den Bakker M.A.
        • van Dalen T.
        • Verhoef C.
        Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study.
        Ann Surg Oncol. 2015; 22: 2817-2823
        • Johner A.
        • Tiwari P.
        • Zetler P.
        • Wiseman S.M.
        Abdominal wall desmoid tumors associated with pregnancy: current concepts.
        Expert Rev Anticancer Ther. 2009; 9: 1675-1682
        • Fiore M.
        • Coppola S.
        • Cannell A.J.
        • Colombo C.
        • Bertagnolli M.M.
        • George S.
        • et al.
        Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.
        Ann Surg. 2014; 259: 973-978
        • De Cian F.
        • Delay E.
        • Rudigoz R.C.
        • Ranchere D.
        • Rivoire M.
        Desmoid tumor arising in a cesarean section scar during pregnancy: monitoring and management.
        Gynecol Oncol. 1999; 75: 145-148
        • Desmoid Tumor Working G.
        The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients.
        Eur J Cancer. 2020; 127: 96-107
        • Colombo C.
        • Miceli R.
        • Le Pechoux C.
        • Palassini E.
        • Honore C.
        • Stacchiotti S.
        • et al.
        Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients.
        Eur J Cancer. 2015; 51: 186-192
        • Robinson W.A.
        • McMillan C.
        • Kendall A.
        • Pearlman N.
        Desmoid tumors in pregnant and postpartum women.
        Cancers. 2012; 4: 184-192
        • Eisenhauer E.A.
        • Therasse P.
        • Bogaerts J.
        • Schwartz L.H.
        • Sargent D.
        • Ford R.
        • et al.
        New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
        Eur J Cancer. 2009; 45: 228-247
        • Colombo C.
        • Fiore M.
        • Grignani G.
        • Tolomeo F.
        • Merlini A.
        • Palassini E.
        • et al.
        A prospective observational study of active surveillance in primary desmoid fibromatosis.
        Clin Cancer Res. 2022; 28: 4027-4032
        • van Houdt W.J.
        • Husson O.
        • Patel A.
        • Jones R.L.
        • Smith M.J.F.
        • Miah A.B.
        • et al.
        Outcome of primary desmoid tumors at all anatomic locations initially managed with active surveillance.
        Ann Surg Oncol. 2019; 26: 4699-4706
        • Penel N.
        • Le Cesne A.
        • Bonvalot S.
        • Giraud A.
        • Bompas E.
        • Rios M.
        • et al.
        Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma Group.
        Eur J Cancer. 2017; 83: 125-131
        • Timbergen M.J.M.
        • Schut A.W.
        • Grunhagen D.J.
        • Sleijfer S.
        • Verhoef C.
        Active surveillance in desmoid-type fibromatosis: a systematic literature review.
        Eur J Cancer. 2020; 137: 18-29
        • Burtenshaw S.M.
        • Cannell A.J.
        • McAlister E.D.
        • Siddique S.
        • Kandel R.
        • Blackstein M.E.
        • et al.
        Toward observation as first-line management in abdominal desmoid tumors.
        Ann Surg Oncol. 2016; 23: 2212-2219
        • Domont J.
        • Salas S.
        • Lacroix L.
        • Brouste V.
        • Saulnier P.
        • Terrier P.
        • et al.
        High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.
        Br J Cancer. 2010; 102: 1032-1036
        • Lazar A.J.
        • Tuvin D.
        • Hajibashi S.
        • Habeeb S.
        • Bolshakov S.
        • Mayordomo-Aranda E.
        • et al.
        Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.
        Am J Pathol. 2008; 173: 1518-1527
        • Salas S.
        • Chibon F.
        • Noguchi T.
        • Terrier P.
        • Ranchere-Vince D.
        • Lagarde P.
        • et al.
        Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.
        Genes Chromosomes Cancer. 2010; 49: 560-568
        • Nachiappan S.
        • Markar S.
        • Karthikesalingam A.
        • Ziprin P.
        • Faiz O.
        Prophylactic mesh placement in high-risk patients undergoing elective laparotomy: a systematic review.
        World J Surg. 2013; 37: 1861-1871
        • Gennatas S.
        • Chamberlain F.
        • Smrke A.
        • Stewart J.
        • Hayes A.
        • Roden L.
        • et al.
        A timely oral option: single-agent vinorelbine in desmoid tumors.
        Oncol. 2020; 25: e2013-e2016
      2. SpringWorks therapeutics announces Nirogacestat achieved primary and all key secondary endpoints in phase 3 DeFi trial in adult patients with progressing desmoid tumors [press release].
        SpringWorks Therapeutics. 24 May 2022;
        • Macfarlane A.J.
        • Blondel B.
        • Mohangoo A.D.
        • Cuttini M.
        • Nijhuis J.
        • Novak Z.
        • et al.
        Wide differences in mode of delivery within Europe: risk-stratified analyses of aggregated routine data from the Euro-Peristat study.
        BJOG. 2016; 123: 559-568
        • Reitamo J.J.
        • Scheinin T.M.
        • Hayry P.
        The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor.
        Am J Surg. 1986; 151: 230-237
        • Enzinger F.M.
        • Shiraki M.
        Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid). Analysis of thirty cases followed up for ten or more years.
        Cancer. 1967; 20: 1131-1140
        • Icard P.
        • Le Rochais J.P.
        • Galateau F.
        • Evrard C.
        Desmoid fibromatosis of the shoulder and of the upper chest wall following a clavicular fracture.
        Eur J Cardio Thorac Surg. 1999; 15: 723-725